Bruns Ingmar
Zentalis Pharmaceuticals, Inc. · Chief Medical Officer
Bruns Ingmar is listed in public filings as officer: Chief Medical Officer. This Bruns Ingmar insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Zentalis Pharmaceuticals, Inc. (ZNTL). Investors use Bruns Ingmar's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $80k33.3k shares | SellFeb 9, 2026 | $802335 shares | $2.39 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $82k33.7k shares | SellFeb 6, 2026 | $7.2K3k shares | $2.43 | -- | |
| $1.0M365k shares | Grant / ExerciseJan 8, 2026 | $1.0M365k shares | $2.84 | -- | |
| $84k36.6k shares | BuyFeb 6, 2025 | $45.7K20k shares | $2.28 | -- | |
| --16.6k shares | Grant / ExerciseFeb 3, 2025 | Disclosure amount unavailable16.6k shares | -- | -- | |
| $28k16.6k shares | Grant / ExerciseFeb 3, 2025 | $27.9K16.6k shares | $1.68 | -- | |
| $2.6M712.7k shares | Grant / ExerciseDec 2, 2024 | $2.6M712.7k shares | $3.66 | -- |